Organigram Holdings Inc. Revenue

Revenue of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue growth rates and interactive chart. Revenue is the income generated from normal business operations and includes discounts and deductions for returned merchandise. It is the top line or gross income figure from which costs are subtracted to determine net income.


Highlights and Quick Summary

  • Revenue for the quarter ending August 31, 2022 was $35.4 Million (a 18.01% increase compared to previous quarter)
  • Year-over-year quarterly Revenue increased by 49.23%
  • Annual Revenue for 2022 was $115 Million (a 82.46% increase from previous year)
  • Annual Revenue for 2021 was $62.8 Million (a -5.17% decrease from previous year)
  • Annual Revenue for 2020 was $66.3 Million (a 9.58% increase from previous year)
  • Twelve month Revenue ending August 31, 2022 was $114 Million (a 15.91% increase compared to previous quarter)
  • Twelve month trailing Revenue increased by 59.2% year-over-year
Trailing Revenue for the last four month:
31 Aug '22 31 May '22 28 Feb '22 30 Nov '21
$114 Million $98.5 Million $85.3 Million $71.8 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue of Organigram Holdings Inc.

Most recent Revenueof OGI including historical data for past 10 years.

Interactive Chart of Revenue of Organigram Holdings Inc.

Organigram Holdings Inc. Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $35.42 $30.01 $25.07 $114.64
2021 $23.73 $19.73 $16.8 $11.49 $62.83
2020 $14.68 $15.02 $12.9 $17.63 $66.26
2019 $19.03 $12.47 $18.46 $20.21 $60.46
2018 $9.51 $2.52 $9.56
2017 $4.24
2016 $4.68

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic